Intuitive Surgical, Inc. (ISRG)
| Market Cap | 172.16B |
| Revenue (ttm) | 9.15B |
| Net Income (ttm) | 2.61B |
| Shares Out | 358.48M |
| EPS (ttm) | 7.17 |
| PE Ratio | 66.99 |
| Forward PE | 56.08 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,436,359 |
| Open | 480.02 |
| Previous Close | 477.08 |
| Day's Range | 476.50 - 482.04 |
| 52-Week Range | 425.00 - 616.00 |
| Beta | 1.60 |
| Analysts | Buy |
| Price Target | 602.53 (+25.46%) |
| Earnings Date | Jul 22, 2025 |
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,... [Read more]
Financial Performance
In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for ISRG stock is "Buy." The 12-month stock price target is $602.53, which is an increase of 25.46% from the latest price.
News
Intuitive Surgical Has More Room To Grow
Intuitive Surgical's da Vinci system is driving strong global growth, with 17% YoY procedure growth and expanding adoption across hospitals and specialties. Recurring revenue streams from system sales...
Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025
We added key positions in Masimo, Exact Sciences, Eli Lilly, Penumbra, and Edwards Lifesciences, each with strong growth drivers and market leadership. Our investment in Masimo is supported by divesti...
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...
Intuitive Surgical, Inc. (ISRG) Q2 2025 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ:ISRG) Q2 2025 Earnings Conference Call July 22, 2025 4:30 PM ET Company Participants David J. Rosa - CEO & Director Jamie E.
Intuitive Surgical reports upbeat quarterly earnings on strong demand for surgical robots
Intuitive Surgical beat Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by growing demand for its surgical robots used in minimally invasive procedures.
Intuitive Announces Second Quarter Earnings
SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...
Intuitive Surgical: If You're Looking For A Dip To Buy, Get It Now (Rating Upgrade)
Intuitive Surgical's premium valuation is justified by consistent mid-teens growth, a dominant market position, and a resilient razor-and-blade business model. Recent innovations like telesurgery and ...
Lucid Motors ($LCID) | Uber ($UBER) | Intuitive ($ISRG) | WeRide ($WRD) | Vertical Aerospace ($EVTL)
Welcome to the Green Stock News brief for Thursday July 17th. Here are today's top headlines: Lucid Motors (NASDAQ: LCID), Nuro, and Uber (NYSE: UBER) have announced an exclusive next-generation robot...
Vessel Sealer Curved receives FDA clearance
Intuitive's latest advanced energy instrument features a unique curved tip for enhanced precision Intuitive's latest advanced energy instrument features a unique curved tip for enhanced precision
Intuitive's da Vinci 5 Surgical System Receives CE Mark
Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures Fifth-generation da Vinci surgical system approved for use in Europe across multiple procedures
Intuitive Surgical Stock: Why This Correction Is Healthy And What Lies Ahead
Intuitive Surgical ISRG is currently in Phase 17 of its 18-Phase Adhishthana Cycle. While the recent correction may be causing concern among investors, from the perspective of Adhishthana Principles, ...
Intuitive Surgical stock dubbed a ‘premier, high-growth' name despite first sell rating
Intuitive Surgical Inc. (NASDAQ: ISRG) is deep in the red this morning after Deutsche Bank issued a bearish note on the biotechnology giant based out of Sunnyvale, California.
Intuitive Surgical Stock Falls. The MedTech Company Gets Its First Sell Rating.
Deutsche Bank is the first group on Wall Street to issue a Sell rating on shares of Intuitive Surgical.
Cramer's Stop Trading: Intuitive Surgical
CNBC's Jim Cramer explains why he is keeping an eye on shares of Intuitive Surgical.
Trade Tracker: Stephanie Link sells Nextera and buys more Intuitive Surgical
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
AVGO Beat and Raise? Plus, Demmert's Stock Picks: ISRG, BYDDY
James Demmert drops by the NYSE set with a couple of stocks to watch: Intuitive Surgical (ISRG) and BYD (BYDDY). He says both are plays that avoid a potential U.S. slowdown.
How pet medicine stocks could cushion your healthcare investments from Trump changes
Moderna shares are seeing a boost on Monday after the US Food and Drug Administration (FDA) gave the pharmaceutical giant limited approval for its lower-dose COVID-19 vaccine. Morgan Stanley Investmen...
Intuitive Surgical: More Than Robots - Why Its AI-Powered Platform Deserves A Premium
Intuitive Surgical's deep R&D investment and da Vinci 5 platform create a powerful innovation moat and embed the company further into surgical workflows. Recurring revenue from a growing installed bas...
Intuitive Surgical: Moat, Resilience But High Market Expectations
Intuitive Surgical remains a dominant leader in robotic surgery with strong recurring revenues, high switching costs, and robust financial health. Business fundamentals are excellent, with resilient p...
Intuitive Surgical: The Business Model Of Robotic Surgery Supports A Bullish Outlook
Intuitive Surgical's share price has rebounded after a sharp drop, driven by strong Q1 2025 results and easing tariff concerns, with further upside expected. As the dominant leader in robotic surgery,...
Intuitive Announces CEO Transition Effective July 1, 2025
President Dave Rosa promoted to CEO Current CEO Gary Guthart to become executive chair of Intuitive's board Current Board Chair Craig Barratt to become lead independent director
Trade Tracker: Stephanie Link sells Eli Lilly and buys more Intuitive Surgical
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
Stock Picks From Seeking Alpha's April 2025 New Analysts
In April, Seeking Alpha welcomed 20 new analysts. This article introduces them and showcases some of their top picks. Top picks include Palantir, Arch Capital Group, and Utah Medical Products, emphasi...